Core Laboratories (CLB) PT Lowered to $18.20 at Bernstein
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $9.65 --0%
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 33 | New: 6
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 33 | New: 6
Join SI Premium – FREE
Bernstein analyst Nicholas Green lowered the price target on Core Laboratories (NYSE: CLB) to $18.20 (from $37.40) while maintaining a Market Perform rating.
You May Also Be Interested In
- Arm Holdings (ARM) PT Lowered to $245 at JPMorgan
- Edwards Lifesciences (EW) PT Raised to $120 at JPMorgan
- Pattern Group Inc (PTRN) PT Raised to $29 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
